Multidrug resistance and mutagenesis

This publication has 89 references indexed in Scilit:

• Design of NDA Intercalators To Overcome Topoisomerase II-Mediated Multidurg Resistance
  JNCI Journal of the National Cancer Institute, 1990
• Protection by inhibitors of multidrug resistance against mitochondrial mutagenesis in Saccharomyces cerevisiae
  European Journal of Cancer and Clinical Oncology, 1990
• Localization of a nonintercalative DNA binding antitumour drug in mitochondria: Relationship to multidrug resistance
  European Journal of Cancer and Clinical Oncology, 1989
• Verapamil as a co-mutagen in the Salmonella/mammalian microsome mutagenicity test
  Mutation Research Letters, 1988
• Intrinsic multidrug resistance phenotype of chinese hamster (rodent) cells in comparison to human cells
  Biochemical and Biophysical Research Communications, 1988
• Inverse correlation between bacterial frameshift mutagenicity and yeast mitochondrial effects of antitumour anilinoacridines
  Chemico-Biological Interactions, 1985
• Comparative studies of mutagenic, DNA binding and antileukaemic properties of 9-anilinoacridine derivatives and related compounds
  Chemico-Biological Interactions, 1983
• Relative sensitivity of V79 and V79/79 cells to spontaneous and induced mutation to 6-thioguanine and ouabain resistance
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982
• The relationship between frameshift mutagenicity and DNA-binding affinity in a series of acridine-substituted derivatives of the experimental antitumour drug 4′-(9-acridinylamino)methanesulphonanilide (AMSA)
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1981
• Ethidium bromide induced mutation of yeast mitochondria: Complete transformation of cells into respiratory deficient non-chromosomal “petites”
  Biochemical and Biophysical Research Communications, 1968